A Novel Thrombomodulin Gene Mutation in a Patient Suffering from Sagittal Sinus Thrombosis

Summary

Thrombomodulin is an endothelial cell membrane glycoprotein that promotes protein C activation. It has been clearly demonstrated that the anticoagulant functions of the protein C system are important in the prevention of thromboembolic disease. Patients with protein C or protein S deficiency and/or resistance to activated protein C (APC resistance) are at higher risk for developing thromboembolic disease. The first mutation in the thrombomodulin gene was discovered in an American patient suffering from pulmonary embolism at the age of 45 (Öhlin and Marlar 1995). Here we report a case of sagittal sinus thrombosis in a 42-year-old Swedish woman. She was found to carry a heterozygous point mutation changing G¹²⁷ to A, predicting an Ala²⁵ to a Thr change in the mature thrombomodulin protein. This mutation was also found in her 16-year-old daughter, who so far has not suffered from any thrombotic events. The patient had no other detectable prothrombotic genetic defects associated with the coagulation system. This case supports the hypothesis of an association between mutations in the thrombomodulin gene and venous thrombosis.

• References

• 1 Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB Journal 1995; 9: 946-955
• 2 Esmon CT, Schwarz HP. An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends in Cardiovascular Medicine 1995; 5: 141-148
• 3 Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalysed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947
• 4 Esmon NL, Caroll RC, Esmon CT. Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983; 258: 12238-12242
• 5 Jackman RW, Beeler DL, Van DeWater L, Rosenberg RD. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. Proc Natl Acad Sci 1986; 83: 8834-8838
• 6 Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-1897
• 7 Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE. Human thrombomodulin: complete cDNA sequence and chromosome localisation of the gene. Biochemistry 1987; 26: 4350-4357
• 8 Lane DA, Mannuci PM, Bauer KA, Bertina RM, Bochov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-662
• 9 Lane DA, Mannuci PM, Bauer KA, Bertina RM, Bochov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824-834
• 10 Ӧhlin A-K, Marlar RA. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 1995; 85: 330-336
• 11 Svensson PJ, Zӧller B, Dahlbäck B. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemost 1997; 77: 332-335
• 12 van derVelden PA, Krommenhoek-Van EsT, Allaart CF, Bertina RM, Reitsma PH. A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia. Thromb Haemost 1991; 65 (05) 511-513
• 13 Norlund L, Holm J, Zӧller B, Ӧhlin A-K. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 1997; 77 (02) 248-251
• 14 Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75: 329-336
• 15 Conway EM, Pollefeyt S, Collen D, Steiner-Mosonyi M. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endo-cytosis. Blood 1997; 89: 652-661
• 16 Tsiang M, Lentz SR, Sadler JE. Functional domains of membrane-bound human thrombomodulin. J Biol Chem 1992; 267: 6164-6170
• 17 Miletch JP, Prescort SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480
• 18 Zӧller B, Bemtsdotter AA, Garcia deFrutos P, Dahlbäck B. Resistance to activated protein C as an additional risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523
• 19 Koeleman BPC, Reitsma PH, Allaart RC, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035
• 20 Ambruso DR, Jacobsen LJ, Hathaway WE. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics 1980; 65: 125-131
• 21 Roos KL, Pascuzzi RM, Kuharik MA, Shapiro AD, Manco-Johnson MJ. Postpartum intracranial venous thrombosis associated with dysfunctional protein C and deficiency of protein S. Obst Gynecol 1990; 76: 492-494
• 22 Cros D, Comp PC, Beltran G, Gum G. Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke 1990; 21: 633-636
• 23 Koelman JHTM, Bakker CM, Plandsoen WCG, Peeters FLM, Barth PG. Hereditary protein S defiency presenting with cerebral sinus thrombosis in an adolescent girl. J Neurol 1992; 239: 105-106
• 24 Zuber M, Toulon P, Mamet L, Mas J-L. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996; 27: 1721-1723
• 25 Deschiens M-A, Conrad J, Horellou H, Ameri A, Preter M, Chedru F, Samama MM, Bousser M-G. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27: 1724-30